Abbott issues US alert over troponin test
This article was originally published in Clinica
Executive Summary
Abbott Diagnostics has issued a voluntary, US recall of its heart injury diagnostic test, Architect Stat Troponin-I. The Abbott Park, Illinois company received complaints concerning inconsistent or invalid test results, but is advising customers to continue use of the product with updated instructions for use (IFU), which are being distributed to clinical labs.